Evaluation of the effectiveness of a proposed approach to treat infertility against the background of uterine leiomyoma, which includes treatment with a releasing hormone agonist, hysteroresectoscopy or conservative myomectomy, and pre-pregnancy treatment

  • S. V. Khmil I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine
  • Yu. B. Drozdovska Medical Center "The Clinic of Professor Stefan Khmil", Ternopil, Ukraine
Keywords: uterine leiomyoma, myomectomy, pre-pregnancy treatment, effectiveness.

Abstract

There is much discussion about the effect of uterine leiomyomas on the outcomes of assisted reproductive technologies (ART). This study aimed to analyze the effectiveness of in vitro fertilization following the use of a therapy scheme we propose to treat infertility with the background of uterine leiomyoma. The therapy scheme includes the use of a releasing hormone agonist, hysteroresectoscopy or conservative myomectomy and pre-pregnancy pre-treatment. The clinical study involved 175 women of reproductive age who had been diagnosed with uterine leiomyoma, and were divided into the groups as follows. The treatment group A included 137 women with uterine leiomyoma, and was further divided into subgroups. Subgroup A1 included 55 women with uterine leiomyoma after conservative myomectomy who underwent the proposed treatment scheme (TS); A2 included 45 women with uterine leiomyoma after hysteroresectoscopy who underwent the TS; A3 included 37 women with uterine leiomyoma who underwent the TS but not the surgical removal of uterine leiomyoma. Control group B included 38 women with uterine leiomyoma after conservative myomectomy. All patients with intramural and submucosal myoma nodules underwent a hormonal preparatory treatment with a gonadotropin-releasing hormone (GnRH) agonist (Diphereline 3.75 mg intramuscularly once every 28 days for 3 months) prior to the myomectomy. After the surgery, patients were prescribed a combination therapy with a vitamin complex FT 500 plus, vitamin D3 and Pelvidol for three months before and during controlled ovarian stimulation (COS) protocol up to the follicle puncture. We determined that the incidence of pregnancy was the lowest (37.8 %) in women with infertility against the background of uterine leiomyoma, who surgically treated for the myomas, but underwent pre-pregnancy pre-treatment. The frequency of pregnancy did not differ between the A1 and A2 treatment groups, and was on average 7.0 % higher than in the control group, and 11.0 % higher than in the A3 group. The relative incidence of clinical pregnancies was the highest in A1 (45.5 %) and A2 (44.4 %) treatment groups. The frequency of live births in the A1 group was significantly higher than in A3 group (by 14.0 %), while the relative number of term live births in the A1 group exceeded that of A3 group by 26.0 %. Thus, both proposed therapy schemes to treat infertility against the background of uterine leiomyoma, which include the use of a releasing hormone agonist, either a conservative myomectomy or hysteroresectoscopy and pre-pregnancy pre-treatment in addition to the ART protocol with a multi-vitamin complex with inositol, vitamin D3, alpha-lipoic acid and magnesium, had the equivalent effects on the incidence of clinical pregnancy, however the frequency of live births was highest after conservative myomectomy (84.0 %).

References

[1] Ahdad-Yata, N., Fernandez, H., Nazac, A., Lesavre, M., Pourcelot, A. G., & Capmas, P. (2016). Fertility after hysteroscopic resection of submucosal myoma in infertile women. J. Gynecol. Obstet. Biol. Reprod., 45(6), 563-570. doi: 10.1016/j.jgyn.2015.06.028
[2] Ahmadi, F., Siahbazi, S., Akhbari, F., Eslami, B., & Vosough, A. (2013). Hysterosalpingography finding in intra uterine adhesion (Asherman’ s syndrome): a pictorial essay. Int. J. Fertil. Steril., 7(3), 155-160. PMCID: PMC3914485.
[3] Bendifallah, S., Brun, J. L., & Fernandez, H. (2011). Myomectomy for infertile women: the role of surgery. J. Gynecol. Obstet. Biol. Reprod. (Paris), 40(8), 885-901. doi: 10.1016/j.jgyn.2011.09.014
[4] Canosa, S., Adriaenssens, T., Coucke, W., Dalmasso, P., Revelli, A., Benedetto, C., & Smitz, J. (2017). Zona pellucida gene mRNA expression in human oocytes is related to oocyte maturity, zona inner layer retardance and fertilization competence. Mol. Hum. Reprod., 23(5), 292-303. doi: 10.1093/molehr/gax008
[5] Canosa, S., Paschero, C., Carosso, A., Leoncini, S., Mercaldo, N., Gennarelli, G., ..., & Revelli, A. (2020). Effect of a combination of myo-inositol, alpha-lipoic acid, and folic acid on oocyte morphology and embryo morphokinetics in non-PCOS overweight/obese patients undergoing IVF: a pilot, prospective, randomized study. J. Clin. Med., 9(9), 2949. doi: 10.3390/jcm9092949
[6] Diamanti-Kandarakis, E., & Dunaif, A. (2012). Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev., 33(6), 981-1030. doi: 10.1210/er.2011-1034
[7] Hackethal, A., Westermann, A., Tchartchian, G., Oehmke, F., Tinneberg, H. R., Muenstedt, K., & Bojahr, B. (2011). Laparoscopic myomectomy in patients with uterine myomas associated with infertility. Minim. Invasive Ther. Allied. Technol., 20(6), 338-345. doi: 10.3109/13645706.2010.541922
[8] Hrubosova, E. (2011). Uterine fibroids and their treatment. Ceska Gynekol., 76(2), 152-157.
[9] Jayagopal, V., Kilpatrick, E. S., Jennings, P. E., Hepburn, D. A., & Atkin, S. L. (2003). The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance. JCEM., 88(4), 1528-1533. doi: 10.1210/jc.2002-020557
[10] Khmil, S. V., Drozdovska, Yu. B., Khmil, M. S., & Chudiyovych, N. Ya. (2018). Ефективність гістерорезектоскопії у жінок з безпліддям на фоні лейоміоми матки в програмах допоміжних репродуктивних технологій [Effectiveness of hysterorezectoscopy in women with infertility and uterine fibroids in programs of assisted reproductive technologies]. Вісник соціальної гігієни та організації охорони здоров’я України – Bulletin of social hygiene and health care organization of Ukraine, 4(78), 51-55. doi: 10.11603/1681-2786.2018.4.10030
[11] Klatsky, P. C., Lane, D. E., Ryan, I. P., & Fujimoto, V. Y. (2007). The effect of fibroids without cavity involvement on ART outcomes independent of ovarian age. Hum. Reprod., 22(2), 521-526. doi: 10.1093/humrep/del370
[12] Kroon, B., Johnson, N., Chapman, M., Yazdani, A., & Hart, R. (2011). Fibroids in infertility-consensus statement from ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence). Aust. N. Z. J. Obstet. Gyneaecol., 51(4), 289-295. doi: 10.1111/j.1479-828X.2011.01300.x
[13] Marret, H., Fritel, X., Ouldamer, L., Bendifallah, S., Brun, J. L., De Jesus, I., ..., & Fernandez, H. (2012). Therapeutic management of uterine fibroid tumors: updated French guidelines. Eur. J. Obstet. Gynecol. Reprod. Biol., 165(2), 156-164. doi: 10.1016/j.ejogrb.2012.07.030
[14] Martynova, A. Ye., Smolnikova, V. Yu., Demura, T. A., & Kogan, Ye. A. (2013). Эффективность программы ЭКО у женщин с миомой матки в зависимости от морфофункционального состояния эндометрия [The effectiveness of the IVF program in women with uterine myoma, depending on the morphofunctional state of the endometrium]. Акушерство и гинекология – Obstetrics and Gynecology, (2), 57-61.
[15] Olive, D. L. (2011). The surgical treatment of fibroids for infertility. Semin. Reprod. Med., 29(2), 113-123. doi: 10.1055/s-0031-1272473
[16] Penzias, A. S. (2012). Recurrent IVF failure: other factors. Fertil. Steril., 97(5), 1033-1038. doi: 10.1016/j.fertnstert.2012.03.017
[17] Pier, B. D., & Bates, G. W. (2015). Potential causes of subfertility in patients with intramural fibroids. Fertil. Res. Pract., (1), 12. doi: 10.1186/s40738-015-0005-2
[18] Samejima, T., Koga, K., Nakae, H., Wada-Hiraike, O., Fujimoto, A., Fujii, T., & Osuga, Y. (2015). Identifying patients who can improve fertility with myomectomy. Eur. J. Obstet. Gynecol. Reprod. Biol., (185), 28-32. doi: 10.1016/j.ejogrb.2014.11.033
[19] Sunkara, S. K., Khairy, M., El-Toukhy, T., Khalaf, Y., & Coomarasamy, A. (2010). The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Hum. Reprod., 25(2), 418-429. doi: 10.1093/humrep/dep396
[20] Surrey, E. S., Minjarez, D. A., Stevens, J. M., & Schoolcraft, W. B. (2005). Effect of myomectomy on the outcome of assisted reproductive technologies. Fertil. Steril., 83(5), 1473-1479. doi: 10.1016/j.fertnstert.2004.11.045
[21] Takai, I. U., Kwayabura, A. S., Ugwa, E. A., Idrissa, A., Obed, J. Y., & Bukar, M. (2015). A 10-year review of the clinical presentation and treatment outcome of Asherman's syndrome at a center with limited resources. Ann. Med. Health Sci. Res., 5(6), 442-446. doi: 10.4103/2141-9248.177984
[22] Unfer, V., Facchinetti, F., Orrù, B., Giordani, B., & Nestler, J. (2017). Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr. Connect., 6(8), 647-658. doi: 10.1530/EC-17-0243
[23] Yoshida, M., & Miyake, T. (2019). The outcomes of uterine myomectomy in infertile patients with uterine leiomyomas. Ann. Infert. Rep. Endocrin., 2(1), 1014.
[24] Zepiridis, L. I., Grimbizis, G. F., & Tarlatzis, B. C. (2016). Infertility and uterine fibroids. Best. Pract. Res. Clin. Obstet. Gynaecol., (34), 66-73. doi: 10.1016/j.bpobgyn.2015.12.001
[25] Zhao, J., Liu, S., Wang, Y., Wang, P., Qu, D., Liu, M., ..., & Li, Y. (2019). Vitamin D improves the outcome of in vitro fertilization (IVF) in infertile women with polycystic ovary syndrome and insulin resistance. Minerva Med., 110(3), 199-208. doi: 10.23736/S0026-4806.18.05946-3
Published
2021-11-27
How to Cite
Khmil, S. V., & Drozdovska , Y. B. (2021). Evaluation of the effectiveness of a proposed approach to treat infertility against the background of uterine leiomyoma, which includes treatment with a releasing hormone agonist, hysteroresectoscopy or conservative myomectomy, and pre-pregnancy treatment. Biomedical and Biosocial Anthropology, (40), 54-59. https://doi.org/10.31393/bba40-2020-09